Centre issues guidelines on pharmaceutical innovation for academic institutions

May 07, 2022

New Delhi, May 07 (ANI): The vision of the Department of Pharmaceuticals is to promote the Indian pharma sector as the global leader in quality medicines and to ensure the availability, accessibility and affordability of drugs and medical devices in the country. One of the measures to achieve the vision is to concentrate on Research & Development and innovation. In order to achieve the same, the Department, amongst various other measures, has set up seven National Institutes of Pharmaceutical Education and Research (NIPERs) as institutes of national importance all across the country for imparting quality education and conducting high-end research. NIPERs have recently launched a common research portal for industry and researchers and have also prepared a Common Research Programme based on the national needs and their own expertise and facilities. The department is also soon coming up with a 'Policy to catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India'. In order to encourage innovation and research and to facilitate the entrepreneurship in NIPERs, the Department of Pharmaceuticals, after considering the National Innovation and Startup Policy 2019, National IPR Policy 2016 and similar policies of other institutes/ departments have prepared 'Common Guidelines on Pharmaceutical Innovation and Entrepreneurship' for academic institutions under its control. The policy aims to transform academic research into innovative and commercially applicable technologies/products; build a strong ecosystem for nurturing creativity and entrepreneurial activities and contribute to the self-reliant India mission (Atmanirbhar Bharat).